Millipore Sigma Vibrant Logo

GR11 Anti-IGF-IR (Ab-1) Mouse mAb (αIR3)

This Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) is validated for use in Immunoblotting, IF, IP, Neutralization Studies, Paraffin Sections for the detection of IGF-IR (Ab-1).

Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Anti-IGF-R, Anti-Insulin-Like Growth Factor Receptor

View Products on Sigmaaldrich.com
GR11
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
GR11-100UG
Retrieving availability...
—
Limited Availability Limited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 100 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewRecognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor.
      Catalogue NumberGR11
      Brand Family Calbiochem®
      SynonymsAnti-IGF-R, Anti-Insulin-Like Growth Factor Receptor
      References
      ReferencesRoth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M., 1987. Science 257, 1452.
      Rechler, M.M. and Nissley, S.P., 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S. and Froesch, E.R., 1986. Hormone Res. 24, 121.
      Humbel, R.E., 1984. I. Chemistry; in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York).
      Kull, F.C., et al. 1983. J. Biol. Chem. 258, 6561.
      Product Information
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Negative controlHS27 cells
      Positive controlHepG2 cells
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Key Applications Immunofluorescence
      Immunoprecipitation
      Not Western Blot
      Not Paraffin Sections
      Application NotesImmunoblotting (not recommended)
      Immunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1-2 µg/sample)
      Neutralization Studies (1 µg/ml; use Cat. No. GR11L)
      Paraffin Sections (not recommended)
      Application CommentsAnti-IGF-I Receptor (Ab-1) Mouse mAb (αIR3) immunoprecipitates the α and β subunits of the IGF-I receptor. Blocks IGF-I binding to its receptor and may bind weakly to the insulin receptor. It also inhibits the growth of MCF-7 cells in culture suggesting the IGF-I receptor may be involved in autocrine regulation of cell growth (see application references). Antibody should be titrated for optimal results in indvidual systems.
      Biological Information
      Immunogenpartially purified, human placenta IGF-I receptor
      ImmunogenHuman
      CloneαIR3
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalog Number GTIN
      GR11-100UG 04055977228229

      Documentation

      Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) Certificates of Analysis

      TitleLot Number
      GR11

      References

      Reference overview
      Roth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M., 1987. Science 257, 1452.
      Rechler, M.M. and Nissley, S.P., 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S. and Froesch, E.R., 1986. Hormone Res. 24, 121.
      Humbel, R.E., 1984. I. Chemistry; in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York).
      Kull, F.C., et al. 1983. J. Biol. Chem. 258, 6561.

      Citations

      Title
    • Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.
    • Daniel E. Syroid, et al. (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience 19, 2059-2068.
    • Donald M. Henricks, et al. (1998) Identification of insulin-like growth factor I in bovine seminal plasma and its receptor on spermatozoa: influence on sperm motility. Biology of Reproduction 59, 330-337.
      		•
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-August-2007 RFH
      SynonymsAnti-IGF-R, Anti-Insulin-Like Growth Factor Receptor
      ApplicationImmunoblotting (not recommended)
      Immunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1-2 µg/sample)
      Neutralization Studies (1 µg/ml; use Cat. No. GR11L)
      Paraffin Sections (not recommended)
      DescriptionPurified mouse monoclonal antibody generated by immunizing SJL mice with the specified immunogen and fusing splenocytes with FO mouse myeloma cells (see application references). Recognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor.
      BackgroundThe insulin-like growth factors (IGFs) or somatomedins are mitogenic peptides present in the plasma of human, rat, and other species. Two distinct but chemically related IGFs have been purified from human plasma: IGF-I (Somatomedin C) and IGF-II. They are single chain polypeptides with molecular weights of 7,640 and 7,471, respectively. Types I and II IGF receptors differ in their structure and in their peptide binding specificity. Type I IGF receptors are structurally homologous to insulin receptors and contain α-subunits (Mr=130,000) that bind peptide, and β-subunits (Mr=90,000), which have intrinsic tyrosine kinase activity. The protein-tyrosine kinase activity of the insulin receptor and, presumably the IGF-I receptor, is required for insulin to stimulate all of its biological responses in cells. Type II receptors are a single polypeptide (Mr=260,000), lack protein-tyrosine kinase activity, and have been shown to be identical to the mannose-6-phosphate receptor.
      HostMouse
      Immunogen speciesHuman
      Immunogenpartially purified, human placenta IGF-I receptor
      CloneαIR3
      IsotypeIgG₁
      Specieshuman
      Positive controlHepG2 cells
      Negative controlHS27 cells
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsAnti-IGF-I Receptor (Ab-1) Mouse mAb (αIR3) immunoprecipitates the α and β subunits of the IGF-I receptor. Blocks IGF-I binding to its receptor and may bind weakly to the insulin receptor. It also inhibits the growth of MCF-7 cells in culture suggesting the IGF-I receptor may be involved in autocrine regulation of cell growth (see application references). Antibody should be titrated for optimal results in indvidual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesRoth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M., 1987. Science 257, 1452.
      Rechler, M.M. and Nissley, S.P., 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S. and Froesch, E.R., 1986. Hormone Res. 24, 121.
      Humbel, R.E., 1984. I. Chemistry; in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York).
      Kull, F.C., et al. 1983. J. Biol. Chem. 258, 6561.
      Citation
    • Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.
    • Daniel E. Syroid, et al. (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience 19, 2059-2068.
    • Donald M. Henricks, et al. (1998) Identification of insulin-like growth factor I in bovine seminal plasma and its receptor on spermatozoa: influence on sperm motility. Biology of Reproduction 59, 330-337.
      		•

      Related Products & Applications

      Related Products

      Catalog Number Description  
      GR11L Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) Show Pricing & Availability

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies